You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.
The international firm is one of several pharmaceutical companies emphasizing new single-cell technologies to improve existing drugs and find new ones.
The NAM, NAS, and Royal Society have formed a commission to develop a framework on the proper use of genome editing, and convened its first meeting in Washington, DC, this week.
By analyzing metagenomic sequences found in thousands of human mouth and gut samples, researchers tracked down almost 45.7 million distinct microbial genes.
In PNAS this week: emerging songbird pathogen Mycoplasma gallisepticum, CRISPR-Cas9-based knockdown finds role for lipoprotein transport in viability, and more.
In Cell this week: malignant cellular states in glioblastoma, method for predicting long-term outcomes among cancer patients, and more.
Researchers developed a system for continuous evolution of base editors, which should continue to improve their functionality.
Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.
In PNAS this week: mathematical model of metastatic seeding, mitochondrial mutation effects, and more.
The new partnership will support the analysis of glycans in 30,000 human samples by the end of 2021.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.